Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid

European Journal of Pharmacology

Volumn 362, Issue 1, 1998, Pages

  Mechoulam, Raphael ^a   Fride, Ester ^a   Ben Shabat, Shimon ^a   Meiri, Uri ^b   Horowitz, Michal ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

2 Arachidonoyl glycerol; Cannabinoid; Hypotension

Indexed keywords

2 ARACHIDONOYLGLYCEROL; CANNABINOID; CARBACHOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; ENDOTHELIUM DERIVED RELAXING FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; CONTROLLED STUDY; HYPERTENSION; MALE; PRIORITY JOURNAL; RAT; SHORT SURVEY; VASCULAR RING;

EID: 0032407065     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00777-8     Document Type: Article

References (8)

1. Ben-Shabat, S., Fride, E., Sheskin, T., Tamiri, T., Rhee, M.-H., Vogel, Z., Bisogno, T., De Petrocellis, L., Di Marzo, V., Mechoulam, R., 1998. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachdonoyl-glycerol cannabinoid activity. Eur. J. Pharmacol. 353, 23-31.
2. Devane, W.A., Hanuš, L., Breuer, A., Pertwee, R.G., Stevenson, L.A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., Mechoulam, R., 1992. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258, 1946-1949.
3. Edwards, G., Weston, A.H., 1998. Endothelium-derived hyperpolarizing factor - a critical appraisal. In: Jucker, E. (Ed.), Progress in Drug Research, Vol. 50. Birkhauser Verlag, Basel, pp. 107-133.
4. Mechoulam, R., Ben-Shabat, S., Hanuš, L., Ligumsky, M., Kaminski, N.E., Schatz, A.R., Gopher, A., Almog, S., Martin, B.R., Compton, D.R., Pertwee, R.G., Griffin, G., Bayewitch, M., Barg, J., Vogel, Z., 1995. Identification of an endogenous 2-mono-glyceride, present in canine gut, that binds to cannabinoid receptors. Biochem. Pharmacol. 50, 83-90.
5. Moncada, S., Palmer, R.M., Higgs, E.A., 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 109-142.
6. Randall, M.D., Kendall, D.A., 1998. Endocannabinoids: a new class of vasoactive substances. Trends Pharmacol. Sci. 19, 55-58.
7. Shochina, M., Horowitz, M., 1989. Central venous pressure, arterial pressure and hypovolemia: their role in adjustment during heart stress. J. Therm. Biol. 14, 109-113.
8. Varga, K., Wagner, J.A., Bridgen, D.T., Kunos, G., 1998. Platelet- and macrophage-derived endogenous cannabinoids are involved in endotoxin-induced hypotension. FASEB J. 12, 1035-1044.